gallbladder problems Tagged Articles
Yaz generics, lawsuits take bite out of Bayer’s profits
Sales of Yaz birth control pills fell 15 percent in the second quarter of 2010, which Bayer Corp. blames on increased competition from generics marketed in the United States by Teva Pharmaceutical Industries. Teva introduced its Yaz copycat, Gianvi, earlier
Bayer drops lawsuit against Teva over Yaz/Gianvi, but the fight continues
Bayer has dropped its patent suit in Delaware against Teva Pharmaceuticals Industries Ltd., and Barr Pharmaceuticals for infringing on its multi-million-dollar-selling oral contraceptive Yaz. Bayer had filed the lawsuit claiming TVA’s generic version of Yaz, known as Gianvi, infringed on
Another woman files lawsuit against makers of Yaz
A Louisiana woman is suing Bayer Corporation claiming the company’s top-selling birth control pill Yaz caused her to develop life-threatening blood clots in her lungs. Heather Gillespie claims that the makers of the oral contraceptive, also known as Yasmin and
Women deserve safer options in birth control
The contraceptive business has boomed since the birth control pill hit the market 50 years ago. Now birth control comes in the form of pills, patches, rings, implants and intrauterine devices, and the makers of such products claim they are
Bayer’s drug sales suffer due to bad press on Yaz blood clot risk
Bayer boasted a 63.1 percent increase in net income for the first quarter of 2010, but the firm’s pharmaceutical sales were a big disappointment, according to PharmaTimes. Bayer posted increases in its earnings before interest, taxes, depreciation and amortization as
Bayer Healthcare still stands behind safety of Yaz, Yasmin
When Bayer Healthcare launched its new style birth control pills Yasmin and Yaz in 2001 and 2006, respectively, the drugs were marketed under the guise that they were safer than other oral contraceptives. Formulated with a synthetic hormone and containing
Lawsuits claim Nuvaring is just as dangerous as Ortho Evra patch, Yaz
Another contraceptive for women is finding its way into the courtroom, following in the footsteps of Bayer Healthcare’s Yaz pill and Johnson & Johnson’s Ortho Evra patch. This time Merck & Co. Inc., is facing a slew of lawsuits over
Yasmin birth control pill to receive label changes
Bayer Schering Pharma has announced it will update the label in the European market for its oral contraceptive Yasmin, a combination of ethinylestradiol and the diuretic drospirenone, also known by the brand name Yaz and the generic brand Ocella. The
